New

Dermatology OTC Drug Market

2021

Dermatology OTC Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-fungal, Wart Remover, Others); Route of Administration (Topical, Oral); Distribution Channel (Online Distribution, Hospital and Retail Pharmacies, Super and Hyper Markets), and Geography

| Report Code: TIPRE00019310 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Dermatology OTC Drug Market 2028 By Indication, Route of Administration, Distribution Channel, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Over the counter (OTC) medicines are also known as non-prescribed medicines. These medicines do not require the supervision of physicians or healthcare professionals. Patients can use them as per the directions mentioned on the labels. Most dermatological drugs are available as OTC drugs and are predominantly sold in topical forms such as gels and ointments.

MARKET DYNAMICS

The dermatology OTC drug market growth is estimated to grow due to the increasing production of generic drugs, rise in demand for topical products to treat skin conditions, and increasing sales of OTC products. The growing pharmaceutical industry in the developing regions is likely to contribute significantly during the forecast period.

MARKET SCOPE

The "Dermatology OTC Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of dermatology OTC drug market with detailed market segmentation by indication, route of administration, and distribution channel. The dermatology OTC drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in dermatology OTC drug market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The dermatology OTC drug market is segmented on the basis of, indication, route of administration, and distribution channel. Based on indication, the market is classified as dermatitis, acne, psoriasis, skin bleaching, anti-fungal, wart remover, and others. Based on route of administration, the market is segmented as topical, and oral. On the basis of distribution channel, the market is segmented as online distribution, hospital and retail pharmacies, and super and hyper markets.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the dermatology OTC drug market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dermatology OTC drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting dermatology OTC drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the dermatology OTC drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the dermatology OTC drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from dermatology OTC drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for dermatology OTC drug market in the global market. Below mentioned is the list of few companies engaged in the dermatology OTC drug market.

The report also includes the profiles of key players in dermatology OTC drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Johnson and Johnson Services, Inc.
  •  Viatris Inc.
  •  Leo Pharma AS
  •  GlaxoSmithKline plc.
  •  Nestlé Skin Health S.A (Gladerma)
  •  Bausch Health Companies Inc.
  •  Perrigo Company plc
  •  ACELLA PHARMACEUTICALS, LLC
  •  Teva Pharmaceutical Industries Ltd.
  •  Sun Pharmaceutical Industries Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dermatology OTC Drug Market - By Indication
1.3.2 Dermatology OTC Drug Market - By Route of Administration
1.3.3 Dermatology OTC Drug Market - By Distribution Channel
1.3.4 Dermatology OTC Drug Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DERMATOLOGY OTC DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DERMATOLOGY OTC DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DERMATOLOGY OTC DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. DERMATOLOGY OTC DRUG - GLOBAL MARKET OVERVIEW
6.2. DERMATOLOGY OTC DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DERMATOLOGY OTC DRUG MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. DERMATITIS
7.3.1. Overview
7.3.2. Dermatitis Market Forecast and Analysis
7.4. ACNE
7.4.1. Overview
7.4.2. Acne Market Forecast and Analysis
7.5. PSORIASIS
7.5.1. Overview
7.5.2. Psoriasis Market Forecast and Analysis
7.6. SKIN BLEACHING
7.6.1. Overview
7.6.2. Skin Bleaching Market Forecast and Analysis
7.7. ANTI-FUNGAL
7.7.1. Overview
7.7.2. Anti-fungal Market Forecast and Analysis
7.8. WART REMOVER
7.8.1. Overview
7.8.2. Wart Remover Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. DERMATOLOGY OTC DRUG MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. TOPICAL
8.3.1. Overview
8.3.2. Topical Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
9. DERMATOLOGY OTC DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. ONLINE DISTRIBUTION
9.3.1. Overview
9.3.2. Online Distribution Market Forecast and Analysis
9.4. HOSPITAL AND RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Hospital and Retail Pharmacies Market Forecast and Analysis
9.5. SUPER AND HYPER MARKETS
9.5.1. Overview
9.5.2. Super and Hyper Markets Market Forecast and Analysis
10. DERMATOLOGY OTC DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Dermatology OTC Drug Market Overview
10.1.2 North America Dermatology OTC Drug Market Forecasts and Analysis
10.1.3 North America Dermatology OTC Drug Market Forecasts and Analysis - By Indication
10.1.4 North America Dermatology OTC Drug Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Dermatology OTC Drug Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Dermatology OTC Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States Dermatology OTC Drug Market
10.1.6.1.1 United States Dermatology OTC Drug Market by Indication
10.1.6.1.2 United States Dermatology OTC Drug Market by Route of Administration
10.1.6.1.3 United States Dermatology OTC Drug Market by Distribution Channel
10.1.6.2 Canada Dermatology OTC Drug Market
10.1.6.2.1 Canada Dermatology OTC Drug Market by Indication
10.1.6.2.2 Canada Dermatology OTC Drug Market by Route of Administration
10.1.6.2.3 Canada Dermatology OTC Drug Market by Distribution Channel
10.1.6.3 Mexico Dermatology OTC Drug Market
10.1.6.3.1 Mexico Dermatology OTC Drug Market by Indication
10.1.6.3.2 Mexico Dermatology OTC Drug Market by Route of Administration
10.1.6.3.3 Mexico Dermatology OTC Drug Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Dermatology OTC Drug Market Overview
10.2.2 Europe Dermatology OTC Drug Market Forecasts and Analysis
10.2.3 Europe Dermatology OTC Drug Market Forecasts and Analysis - By Indication
10.2.4 Europe Dermatology OTC Drug Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Dermatology OTC Drug Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Dermatology OTC Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Dermatology OTC Drug Market
10.2.6.1.1 Germany Dermatology OTC Drug Market by Indication
10.2.6.1.2 Germany Dermatology OTC Drug Market by Route of Administration
10.2.6.1.3 Germany Dermatology OTC Drug Market by Distribution Channel
10.2.6.2 France Dermatology OTC Drug Market
10.2.6.2.1 France Dermatology OTC Drug Market by Indication
10.2.6.2.2 France Dermatology OTC Drug Market by Route of Administration
10.2.6.2.3 France Dermatology OTC Drug Market by Distribution Channel
10.2.6.3 Italy Dermatology OTC Drug Market
10.2.6.3.1 Italy Dermatology OTC Drug Market by Indication
10.2.6.3.2 Italy Dermatology OTC Drug Market by Route of Administration
10.2.6.3.3 Italy Dermatology OTC Drug Market by Distribution Channel
10.2.6.4 Spain Dermatology OTC Drug Market
10.2.6.4.1 Spain Dermatology OTC Drug Market by Indication
10.2.6.4.2 Spain Dermatology OTC Drug Market by Route of Administration
10.2.6.4.3 Spain Dermatology OTC Drug Market by Distribution Channel
10.2.6.5 United Kingdom Dermatology OTC Drug Market
10.2.6.5.1 United Kingdom Dermatology OTC Drug Market by Indication
10.2.6.5.2 United Kingdom Dermatology OTC Drug Market by Route of Administration
10.2.6.5.3 United Kingdom Dermatology OTC Drug Market by Distribution Channel
10.2.6.6 Rest of Europe Dermatology OTC Drug Market
10.2.6.6.1 Rest of Europe Dermatology OTC Drug Market by Indication
10.2.6.6.2 Rest of Europe Dermatology OTC Drug Market by Route of Administration
10.2.6.6.3 Rest of Europe Dermatology OTC Drug Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Dermatology OTC Drug Market Overview
10.3.2 Asia-Pacific Dermatology OTC Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific Dermatology OTC Drug Market Forecasts and Analysis - By Indication
10.3.4 Asia-Pacific Dermatology OTC Drug Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Dermatology OTC Drug Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Dermatology OTC Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Dermatology OTC Drug Market
10.3.6.1.1 Australia Dermatology OTC Drug Market by Indication
10.3.6.1.2 Australia Dermatology OTC Drug Market by Route of Administration
10.3.6.1.3 Australia Dermatology OTC Drug Market by Distribution Channel
10.3.6.2 China Dermatology OTC Drug Market
10.3.6.2.1 China Dermatology OTC Drug Market by Indication
10.3.6.2.2 China Dermatology OTC Drug Market by Route of Administration
10.3.6.2.3 China Dermatology OTC Drug Market by Distribution Channel
10.3.6.3 India Dermatology OTC Drug Market
10.3.6.3.1 India Dermatology OTC Drug Market by Indication
10.3.6.3.2 India Dermatology OTC Drug Market by Route of Administration
10.3.6.3.3 India Dermatology OTC Drug Market by Distribution Channel
10.3.6.4 Japan Dermatology OTC Drug Market
10.3.6.4.1 Japan Dermatology OTC Drug Market by Indication
10.3.6.4.2 Japan Dermatology OTC Drug Market by Route of Administration
10.3.6.4.3 Japan Dermatology OTC Drug Market by Distribution Channel
10.3.6.5 Rest of Asia-Pacific Dermatology OTC Drug Market
10.3.6.5.1 Rest of Asia-Pacific Dermatology OTC Drug Market by Indication
10.3.6.5.2 Rest of Asia-Pacific Dermatology OTC Drug Market by Route of Administration
10.3.6.5.3 Rest of Asia-Pacific Dermatology OTC Drug Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Dermatology OTC Drug Market Overview
10.4.2 Middle East and Africa Dermatology OTC Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa Dermatology OTC Drug Market Forecasts and Analysis - By Indication
10.4.4 Middle East and Africa Dermatology OTC Drug Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Dermatology OTC Drug Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Dermatology OTC Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Dermatology OTC Drug Market
10.4.6.1.1 South Africa Dermatology OTC Drug Market by Indication
10.4.6.1.2 South Africa Dermatology OTC Drug Market by Route of Administration
10.4.6.1.3 South Africa Dermatology OTC Drug Market by Distribution Channel
10.4.6.2 Saudi Arabia Dermatology OTC Drug Market
10.4.6.2.1 Saudi Arabia Dermatology OTC Drug Market by Indication
10.4.6.2.2 Saudi Arabia Dermatology OTC Drug Market by Route of Administration
10.4.6.2.3 Saudi Arabia Dermatology OTC Drug Market by Distribution Channel
10.4.6.3 U.A.E Dermatology OTC Drug Market
10.4.6.3.1 U.A.E Dermatology OTC Drug Market by Indication
10.4.6.3.2 U.A.E Dermatology OTC Drug Market by Route of Administration
10.4.6.3.3 U.A.E Dermatology OTC Drug Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Dermatology OTC Drug Market
10.4.6.4.1 Rest of Middle East and Africa Dermatology OTC Drug Market by Indication
10.4.6.4.2 Rest of Middle East and Africa Dermatology OTC Drug Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Dermatology OTC Drug Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Dermatology OTC Drug Market Overview
10.5.2 South and Central America Dermatology OTC Drug Market Forecasts and Analysis
10.5.3 South and Central America Dermatology OTC Drug Market Forecasts and Analysis - By Indication
10.5.4 South and Central America Dermatology OTC Drug Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Dermatology OTC Drug Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Dermatology OTC Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Dermatology OTC Drug Market
10.5.6.1.1 Brazil Dermatology OTC Drug Market by Indication
10.5.6.1.2 Brazil Dermatology OTC Drug Market by Route of Administration
10.5.6.1.3 Brazil Dermatology OTC Drug Market by Distribution Channel
10.5.6.2 Argentina Dermatology OTC Drug Market
10.5.6.2.1 Argentina Dermatology OTC Drug Market by Indication
10.5.6.2.2 Argentina Dermatology OTC Drug Market by Route of Administration
10.5.6.2.3 Argentina Dermatology OTC Drug Market by Distribution Channel
10.5.6.3 Rest of South and Central America Dermatology OTC Drug Market
10.5.6.3.1 Rest of South and Central America Dermatology OTC Drug Market by Indication
10.5.6.3.2 Rest of South and Central America Dermatology OTC Drug Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Dermatology OTC Drug Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DERMATOLOGY OTC DRUG MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DERMATOLOGY OTC DRUG MARKET, KEY COMPANY PROFILES
13.1. JOHNSON AND JOHNSON SERVICES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. VIATRIS INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. LEO PHARMA AS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE PLC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NESTLé SKIN HEALTH S.A (GLADERMA)
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BAUSCH HEALTH COMPANIES INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PERRIGO COMPANY PLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ACELLA PHARMACEUTICALS, LLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SUN PHARMACEUTICAL INDUSTRIES LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Johnson and Johnson Services, Inc.
2. Viatris Inc.
3. Leo Pharma AS
4. GlaxoSmithKline plc.
5. Nestlé Skin Health S.A (Gladerma)
6. Bausch Health Companies Inc.
7. Perrigo Company plc
8. ACELLA PHARMACEUTICALS, LLC
9. Teva Pharmaceutical Industries Ltd.
10. Sun Pharmaceutical Industries Ltd.
TIPRE00019310
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.